Leping Li
42Patents
10h-index
66Co-inventors
78Inventor score
Filing activity: Mar 9, 1994 → Nov 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5440056A | 9-deoxotaxane compounds | Chemistry; Metallurgy | 52 | Expired |
| US6316503A | LXR modulators | Emerging Cross-Sectional Technologies | 43 | Expired |
| US6046171A | 6,11-bridged erythromycin derivatives | Chemistry; Metallurgy | 26 | Expired |
| US5696084A | Amino-lipopetide antifungal agents | Human Necessities | 24 | Expired |
| US6780858B2 | Antibacterial agents | Chemistry; Metallurgy | 23 | Expired |
| US7148259B1 | Antibacterial agents | Chemistry; Metallurgy | 22 | Expired |
| US7045527B2 | Piperidine derivatives | Chemistry; Metallurgy | 19 | Expired |
| US5616740A | Process for making 9-deoxotaxane compounds | Chemistry; Metallurgy | 18 | Expired |
| US6075011A | 6-O-substituted erythromycin compounds and method for making same | Human Necessities | 13 | Expired |
| US6906069B1 | LXR modulators | Emerging Cross-Sectional Technologies | 12 | Expired |
| US10377748B2 | Hepatitis B core protein modulators | Chemistry; Metallurgy | 7 | Active |
| US5571822A | Antitumor compounds | Human Necessities | 7 | Expired |
| US8877707B2 | Inhibitors of HCV NS5A | Human Necessities | 5 | Active |
| US8618151B2 | Inhibitors of HCV NS5A | Chemistry; Metallurgy | 3 | Active |
| US7572783B2 | Substituted benzofused heterocycles | Chemistry; Metallurgy | 3 | Active |
| US6809104B2 | Fused heterocyclic compounds | Human Necessities | 2 | Expired |
| US8614207B2 | Inhibitors of hepatitis C virus | Chemistry; Metallurgy | 2 | Active |
| US8709999B2 | Substituted bicyclic HCV inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9120779B2 | Inhibitors of HCV NS5A | Chemistry; Metallurgy | 2 | Active |
| US8921369B2 | Inhibitors of HCV NS5A | Chemistry; Metallurgy | 1 | Active |
| US6649593B1 | Modulators of SREBP processing | Human Necessities | 1 | Expired |
| US9309260B2 | Inhibitors of hepatitis C virus | Chemistry; Metallurgy | 1 | Active |
| US8865756B2 | Inhibitors of HCV NS5A | Chemistry; Metallurgy | 1 | Active |
| US6858619B2 | Fused heterocyclic compounds | Human Necessities | 1 | Expired |
| US9150554B2 | Fused ring inhibitors of hepatitis C | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.